Biotricity SG&A Expenses 2015-2024 | BTCY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Biotricity sg&a expenses from 2015 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Biotricity sg&a expenses from 2015 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$10.5B
Hims & Hers Health (HIMS)	$5.7B
Inspire Medical Systems (INSP)	$5.7B
Axonics (AXNX)	$3.6B
IRhythm Technologies (IRTC)	$2.7B
Privia Health (PRVA)	$2.7B
Enovis (ENOV)	$2.6B
Omnicell (OMCL)	$2.3B
Azenta (AZTA)	$2.2B
10x Genomics (TXG)	$1.9B
Schrodinger (SDGR)	$1.6B
Clover Health Investments (CLOV)	$1.6B
Phreesia (PHR)	$1.2B
Standard BioTools (LAB)	$763M
Fulgent Genetics (FLGT)	$586M
Butterfly Network (BFLY)	$571M
Talkspace (TALK)	$569M
Definitive Healthcare (DH)	$528M
Health Catalyst (HCAT)	$495M
Pulmonx (LUNG)	$278M
SOPHiA GENETICS SA (SOPH)	$261M
TruBridge (TBRG)	$234M
P3 Health Partners (PIII)	$140M
American Well (AMWL)	$136M
EUDA Health Holdings (EUDA)	$98M
Future Health ESG (FHLT)	$65M
HeartBeam (BEAT)	$63M
111 (YI)	$56M
CareCloud (CCLD)	$51M
Zepp Health (ZEPP)	$49M